Endocannabinoid System Research: Cannabis in Student Mental Health

Clinical Takeaway

A mobile app called Minder, co-designed with university students, was tested in a randomized controlled trial to evaluate its impact on mental health and substance use outcomes in a general college population. Digital tools like this are being studied because they can reach large numbers of students at a critical life stage when mental health challenges commonly emerge. Results from this trial provide direct clinical evidence on whether app-based interventions can meaningfully support student wellbeing at scale.

#5 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.

Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.

Study type: Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov’t  |  Topic area: Anxiety & PTSD  |  CED Score: 12

Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0

Why This Matters
This study addresses a critical clinical gap by evaluating a scalable digital intervention specifically designed for the high-risk transition period of university attendance, when mental health and substance use disorders frequently emerge. The randomized controlled trial design provides robust evidence for whether mobile app-based interventions can effectively reduce mental health symptoms and substance use in a population that traditionally underutilizes conventional mental health services. If efficacious, Minder’s evidence base could inform adoption of digital mental health tools within university healthcare systems to extend treatment reach and improve outcomes for students with limited access to traditional clinical services.

Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure

Clinical Perspective

🧠 The Minder app study addresses a genuine clinical need, as digital interventions show promise for reaching university students during a vulnerable developmental window when mental health and substance use disorders often emerge. However, several important limitations temper the conclusions: the study population consists of university students, a relatively healthy and tech-literate demographic that may not represent broader populations with more severe or complex presentations, and the effectiveness of any digital intervention depends heavily on engagement and adherence, which can vary substantially in real-world settings beyond controlled trial conditions. Additionally, mobile apps typically work best as adjuncts to standard care rather than replacements, and the absence of data on clinical outcomes like hospitalization or treatment completion rates leaves questions about meaningful impact on disease course. The measured enthusiasm for this tool should acknowledge that positive research outcomes do not always translate to sustained clinical benefit in diverse practice settings. For clinicians, Minder may serve as a reasonable supplementary resource for motivated students seeking additional support between appointments or in settings where traditional counseling access is limited, though it should not displace assessment

Full Article  |  PubMed  |  PMC Full Text